Twelve Guidances For High-Priority FDAMA Provisions Released By CDRH
This article was originally published in The Gray Sheet
Early revisions to 12 device guidance documents implementing high-priority provisions of the FDA Modernization Act likely will be made only in response to comments from manufacturers or other interested groups, agency staffers say.
You may also be interested in...
FDA's propensity to suggest that sponsors hold non-binding "agreement" meetings in lieu of binding "determination" meetings in their pursuit of agency go-ahead is in industry's best interest, Susan Alpert, director of the Center for Devices and Radiological Health's Office of Device Evaluation, maintained.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.